Fairness opinions › Acquirers
Smith & Nephew: healthcare acquisitions with fairness opinions
2 public-company targets, 2014-2019, $2.2B combined enterprise value. The multiples Smith & Nephew paid and the banker analyses behind each target board's recommendation.
Deals
2
Median EV / EBITDA paid
22.4x
Median EV / revenue paid
4.00x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2019-03-13 | Osiris Therapeutics | Smith & Nephew | Medical Devices and Supplies | $660M | 28.8x | 4.19x | 10.5%–12.5% | Cantor Fitzgerald |
| 2014-02-03 | ArthroCare | Smith & Nephew | Medical Devices and Supplies | $1.5B | 16.1x | 3.82x | 9.1%–11.1% | Piper Sandler |